Correlation between phenotype and genotype in a large unselected cohort of children with severe hemophilia A.

Manuel D. Carcao, H. Marijke van den Berg, Rolf Ljung, Maria Elisa Mancuso, [No Value] PedNet

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

Phenotypic variability is well recognized in severe hemophilia A. A few studies, mainly in adults treated lifelong on demand, suggest that bleeding phenotype correlates with factor VIII gene (F8) mutation type. Because treatment regimens influence outcomes to a large extent, examining bleeding phenotype during the first years of life may be the most suitable way to define this variability. We set out to analyze the very early phenotypic expression of severe hemophilia A in 621 consecutively enrolled, well-characterized previously untreated patients and to correlate this with patients' F8 mutation. Detailed information was collected on bleeds and treatment of the first 75 exposure days or until inhibitor development. F8 mutation type was known for 531 patients; 402 had null mutations and 129 had non-null mutations. Considering only patients who had not started prophylaxis or developed an inhibitor before select bleeding events, we found that patients with null mutations experienced their first bleed and first joint bleed at younger median ages than patients with non-null mutations (9.7 vs 10.9 months and 13.8 vs 16.1 months, respectively). We conclude that F8 mutation type accounts for only a small component of the significant phenotypic variability found among patients with severe hemophilia A.

Original languageEnglish
JournalBlood
Volume121
Issue number19
DOIs
Publication statusPublished - May 9 2013

Fingerprint

Factor VIII
Hemophilia A
Genetic Association Studies
Genes
Mutation
Hemorrhage
Phenotype
Joints
Therapeutics

ASJC Scopus subject areas

  • Hematology
  • Biochemistry
  • Cell Biology
  • Immunology

Cite this

Correlation between phenotype and genotype in a large unselected cohort of children with severe hemophilia A. / Carcao, Manuel D.; van den Berg, H. Marijke; Ljung, Rolf; Mancuso, Maria Elisa; PedNet, [No Value].

In: Blood, Vol. 121, No. 19, 09.05.2013.

Research output: Contribution to journalArticle

Carcao, Manuel D. ; van den Berg, H. Marijke ; Ljung, Rolf ; Mancuso, Maria Elisa ; PedNet, [No Value]. / Correlation between phenotype and genotype in a large unselected cohort of children with severe hemophilia A. In: Blood. 2013 ; Vol. 121, No. 19.
@article{bfb49befb0f145e591f8c2af37871b2a,
title = "Correlation between phenotype and genotype in a large unselected cohort of children with severe hemophilia A.",
abstract = "Phenotypic variability is well recognized in severe hemophilia A. A few studies, mainly in adults treated lifelong on demand, suggest that bleeding phenotype correlates with factor VIII gene (F8) mutation type. Because treatment regimens influence outcomes to a large extent, examining bleeding phenotype during the first years of life may be the most suitable way to define this variability. We set out to analyze the very early phenotypic expression of severe hemophilia A in 621 consecutively enrolled, well-characterized previously untreated patients and to correlate this with patients' F8 mutation. Detailed information was collected on bleeds and treatment of the first 75 exposure days or until inhibitor development. F8 mutation type was known for 531 patients; 402 had null mutations and 129 had non-null mutations. Considering only patients who had not started prophylaxis or developed an inhibitor before select bleeding events, we found that patients with null mutations experienced their first bleed and first joint bleed at younger median ages than patients with non-null mutations (9.7 vs 10.9 months and 13.8 vs 16.1 months, respectively). We conclude that F8 mutation type accounts for only a small component of the significant phenotypic variability found among patients with severe hemophilia A.",
author = "Carcao, {Manuel D.} and {van den Berg}, {H. Marijke} and Rolf Ljung and Mancuso, {Maria Elisa} and PedNet, {[No Value]}",
year = "2013",
month = "5",
day = "9",
doi = "10.1182/blood-2012-11-469403",
language = "English",
volume = "121",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "19",

}

TY - JOUR

T1 - Correlation between phenotype and genotype in a large unselected cohort of children with severe hemophilia A.

AU - Carcao, Manuel D.

AU - van den Berg, H. Marijke

AU - Ljung, Rolf

AU - Mancuso, Maria Elisa

AU - PedNet, [No Value]

PY - 2013/5/9

Y1 - 2013/5/9

N2 - Phenotypic variability is well recognized in severe hemophilia A. A few studies, mainly in adults treated lifelong on demand, suggest that bleeding phenotype correlates with factor VIII gene (F8) mutation type. Because treatment regimens influence outcomes to a large extent, examining bleeding phenotype during the first years of life may be the most suitable way to define this variability. We set out to analyze the very early phenotypic expression of severe hemophilia A in 621 consecutively enrolled, well-characterized previously untreated patients and to correlate this with patients' F8 mutation. Detailed information was collected on bleeds and treatment of the first 75 exposure days or until inhibitor development. F8 mutation type was known for 531 patients; 402 had null mutations and 129 had non-null mutations. Considering only patients who had not started prophylaxis or developed an inhibitor before select bleeding events, we found that patients with null mutations experienced their first bleed and first joint bleed at younger median ages than patients with non-null mutations (9.7 vs 10.9 months and 13.8 vs 16.1 months, respectively). We conclude that F8 mutation type accounts for only a small component of the significant phenotypic variability found among patients with severe hemophilia A.

AB - Phenotypic variability is well recognized in severe hemophilia A. A few studies, mainly in adults treated lifelong on demand, suggest that bleeding phenotype correlates with factor VIII gene (F8) mutation type. Because treatment regimens influence outcomes to a large extent, examining bleeding phenotype during the first years of life may be the most suitable way to define this variability. We set out to analyze the very early phenotypic expression of severe hemophilia A in 621 consecutively enrolled, well-characterized previously untreated patients and to correlate this with patients' F8 mutation. Detailed information was collected on bleeds and treatment of the first 75 exposure days or until inhibitor development. F8 mutation type was known for 531 patients; 402 had null mutations and 129 had non-null mutations. Considering only patients who had not started prophylaxis or developed an inhibitor before select bleeding events, we found that patients with null mutations experienced their first bleed and first joint bleed at younger median ages than patients with non-null mutations (9.7 vs 10.9 months and 13.8 vs 16.1 months, respectively). We conclude that F8 mutation type accounts for only a small component of the significant phenotypic variability found among patients with severe hemophilia A.

UR - http://www.scopus.com/inward/record.url?scp=84880473815&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84880473815&partnerID=8YFLogxK

U2 - 10.1182/blood-2012-11-469403

DO - 10.1182/blood-2012-11-469403

M3 - Article

C2 - 23482934

AN - SCOPUS:84880473815

VL - 121

JO - Blood

JF - Blood

SN - 0006-4971

IS - 19

ER -